Argentina Launches Sputnik V Vaccine Production

The Moscow-based Russian Direct Investment Fund (RDIF) and Laboratorios Richmond SACIF pharmaceutical company of Argentina today announced the production of the first batch of the Sputnik V vaccine in Argentina.

Argentina has become the first country in Latin America to register Sputnik V officially. 

Full-scale production of the vaccine is anticipated for June 2021. Sputnik V vaccine produced in Argentina could be exported to Central and Latin America countries at a later stage.

Alberto Fernández, President of Argentina, commented in an RDIF press release issued on April 20, 2021, “We are very excited about the possibility of producing Sputnik V in Argentina, a vaccine with which we are already protecting a large part of our population with excellent results. It will be a great opportunity to advance in the fight against the pandemic not only in Argentina but also in Latin America.”

Marcelo Figueiras, President of Richmond Laboratories, added, “We celebrate this recognition that we will reward with work, commitment, and professionalism, to facilitate the availability of the vaccine in the shortest possible time for Argentina and the entire Latin American region.”

RDIF is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors.